The page is the record's research on the issuer — no analyst, no rating, no view. # uniQure N.V. (NASDAQ: QURE) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is uniQure N.V., listed on NASDAQ under ticker QURE, with ISIN USN900641010. The LEI is not on the record. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its segment and jurisdiction are not on the record. Its listing status is listed, not halted. ## The disclosure read The record holds 114 filings across 51 filing days in the twelve months to 2026-11-08. Of these, 52 are regulatory filings, 36 are directors' dealings, 10 are corporate news, 10 are results, 3 are AGM/EGM notices, 2 are prospectuses and 1 is a director change. The median gap between filing days is 3.5 days. The latest filing is dated 2026-11-06, is a regulatory filing, and is 2 days before the record date. The NASDAQ median cadence gap is 6.0 days, with a median of 52 filings and a median latency of 5.0 days. The sector median cadence gap is 6.0 days, with a median of 63.0 filings and a median latency of 4.0 days. ## Auditor The auditor of record is not on the record, because the latest annual report cover carries no auditor name tag. Its location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, and the segment move is not on the record. The halt flag shows the issuer is listed and not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter was dated 2026-11-04. ## Coverage The issuer's investor-relations page names 14 research houses: Barclays, Cantor Fitzgerald, Goldman Sachs, Guggenheim, H.C. Wainwright, Kempen, Leerink Partners, RBC Capital, Stifel, TD Cowen, UBS, Wells Fargo, William Blair and Wolfe Research. ## Open research No openly published research notes were found. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001590560.json (identity.name) - https://mcp.us-cm-kg.ai/events/NASDAQ/QURE (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://www.uniqure.com/investors-media/analyst-coverage (coverage) - https://mcp.us-cm-kg.ai/record/NASDAQ/QURE (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/QURE · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp